MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib.

Source:http://linkedlifedata.com/resource/pubmed/id/18093943

Proc. Natl. Acad. Sci. U.S.A. 2007 Dec 26 104 52 20932-7

Download in:

View as

Triples

General Info

PMID
18093943